Effects of antibiotic consumption on children 2-8 years of age developing asthma

Hamid Reza Khalkhali1, Sima Oshnouei2, Shaker Salarilak3

  • 1Inpatient Safety Research Center, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran ; Department of Biostatistics and Epidemiology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran.

Insights

Antibiotic use in early childhood is linked to a higher risk of developing asthma. This study found a significant association between antibiotic consumption in the first year of life and increased odds of childhood asthma.

Area of Science:

  • Pediatric Medicine
  • Epidemiology
  • Public Health

Background:

  • Childhood asthma prevalence is rising globally.
  • Antibiotic exposure is a suspected environmental factor contributing to this increase.

Purpose of the Study:

  • To investigate the association between antibiotic exposure and childhood asthma risk.
  • To determine if early-life antibiotic use impacts asthma development in children aged 2-8 years.

Main Methods:

  • A case-control study was conducted in Iran involving 207 asthmatic children (cases) and 400 healthy children (controls) aged 2-8 years.
  • Data on antibiotic exposure and other risk factors were collected via parental interviews using a validated questionnaire.
  • Cases were diagnosed based on Global Initiative for Asthma criteria; controls were matched for age and gender.

Main Results:

  • Antibiotic consumption during the first year of life was associated with a significantly increased odds ratio (OR) for asthma symptoms (adjusted OR, 1.91; 95% CI, 1.27-2.88).
  • This association remained significant after adjusting for potential confounders like family history of asthma, preterm delivery, and birth order.

Conclusions:

  • Early-life antibiotic consumption in children is associated with an elevated risk of developing childhood asthma.
  • Further research is recommended to confirm these findings and explore underlying mechanisms.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
84
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
1.7K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K